Your session is about to expire
← Back to Search
Pelvic Lymphadenectomy for Bladder Cancer
Study Summary
This trial is comparing two types of surgery for invasive bladder cancer - standard vs extended pelvic lymphadenectomy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My cancer is early stage with a low risk of spreading to lymph nodes.My surgery showed cancer in the pelvic lymph nodes near the common iliac vessels.My cancer is at a stage where it has grown but not spread to distant parts.I have had radiation therapy to my pelvic area before.My bladder cancer diagnosis was confirmed through tissue examination.My condition needs major bladder surgery and lymph node removal.My bladder cancer has various types of cells, including urothelial.I can take care of myself and am up and about more than 50% of my waking hours.Your ALT and AST levels are within the normal range.My liver enzyme levels are high, but I've been checked for liver metastases.I've completed neoadjuvant chemotherapy for my cancer and have recovered.I had surgery to remove part of my bladder due to cancer.I've had pelvic surgery that prevents further extensive lymph node removal.My cancer is at a stage where the tumor cannot be moved.My cancer is either squamous cell or adenocarcinoma.I have no cancer history except for certain skin cancers, early-stage cervical cancer, or any stage I or II cancer from which I've been in remission for 5 years.I have not had laparoscopic surgery.My doctor thinks I am fit for bladder removal surgery.Your alkaline phosphatase levels are within the normal range.My cancer has spread to areas near my lower abdomen.
- Group 1: Arm I
- Group 2: Arm II
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there opportunities for new participants to enter this clinical trial?
"Unfortunately, the clinicaltrials.gov page for this trial conveys that it is not currently recruiting patients. While the trial was first listed on August 1st 2011 and last updated July 20th 2022, 373 other studies are actively enrolling participants at present."
How many sites are involved in executing this clinical research?
"Patients interested in this clinical trial can receive treatment at UCSF Medical Center-Mission Bay (San Francisco, California), Washington University School of Medicine (Saint Louis, Missouri) and Yale University (New Haven, Connecticut). Additionally there are 35 other sites."
Does this research permit octogenarian participants?
"To be considered for this investigation, patients must have a chronological age between 18 and 120. There are 10 separate investigations targeting minors while 373 are tailored to elderly applicants."
Do I meet the requisite qualifications to join this investigation?
"For this clinical trial, 658 patients suffering from urinary bladder cancer, aged 18 to 120 years old, are eligible. To qualify, the following conditions must be met: no prior laparoscopic surgery; disease necessitating a radical cystectomy and lymph node dissection for treatment; stage T2 or higher; absence of low-risk nodal metastasis (carcinoma in situ only); presence of micropapillary or minor components of rare phenotype; and lack of pure squamous cell carcinoma/adenocarcinoma."
Share this study with friends
Copy Link
Messenger